|
Volumn 142, Issue 6, 2006, Pages 767-768
|
Breakthrough in the treatment of warts?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA LACTALBUMIN;
IMMUNOSUPPRESSIVE AGENT;
OLEIC ACID;
PLACEBO;
SODIUM CHLORIDE;
BREAST MILK;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
DRUG SOLUTION;
FOLLOW UP;
HUMAN;
HYDROCOLLOID DRESSING;
NOTE;
PRIORITY JOURNAL;
SKIN DEFECT;
SKIN EXAMINATION;
SKIN PAPILLOMA;
TREATMENT OUTCOME;
VERRUCA VULGARIS;
ADMINISTRATION, CUTANEOUS;
DOUBLE-BLIND METHOD;
DRUG COMBINATIONS;
HUMANS;
LACTALBUMIN;
OCCLUSIVE DRESSINGS;
OLEIC ACID;
PAPILLOMAVIRUS INFECTIONS;
PATIENT SELECTION;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH DESIGN;
SKIN DISEASES, VIRAL;
TREATMENT OUTCOME;
WARTS;
|
EID: 33745240997
PISSN: 0003987X
EISSN: 0003987X
Source Type: Journal
DOI: 10.1001/archderm.142.6.767 Document Type: Note |
Times cited : (7)
|
References (0)
|